top of page

2023 GI Symposium

NCSCG 2023 GI Symposium web banner_register_1200x700_v2.png

Dear Colleague,

The Northern California Society for Clinical Gastroenterology (NCSCG) Board and Meeting Planning Committee are pleased to announce that this year’s meeting will be held in-person as a two-day event at the Hyatt Regency Monterey Hotel in Monterey, CA on May 20-21, 2023. 

The symposium will provide a unique opportunity to receive a comprehensive update on gastrointestinal diseases from nationally renowned faculty. You will also have ample opportunity to interact with your colleagues, our expert faculty members, and industry representatives, as well as time to enjoy all that Monterey has to offer.

We have reserved a block of rooms for NCSCG members at Hyatt Regency Monterey Hotel, the location of the 2023 GI symposium. 


We hope you are as excited as we are for in-person learning and networking, and to enjoy the beautiful surrounding Monterey and Monterey Bay.

Click on the link above for complete conference and registration information. Please feel free to contact the NCSCG with any questions or comments by sending an email to  



The NCSCG GI Symposium Planning Committee

Robert Wong, MD; President

Mikhail Alper, PA-C

Nghiem Ha, MD

Bilal Hameed, MD; Treasurer

Neil Stollman, MD

Registration Fees

NCSCG Members

MD,DO,PhD $100

Allied Healthcare Professional $60

Fellow/Resident - Complimentary


MD,DO,PhD $150

Allied Healthcare Professional $100

Additional Industry Representative $400

Fellow/Resident - Complimentary​

To become an NCSCG member or renew your membership click here

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners involved in the care of patients with gastrointestinal disorders.

Statement of Need

The goal of this program is to provide important clinical and scientific data on the management of gastrointestinal disorders.


Learning Objectives

Upon completion of this symposium, participants should be better able to:

  • Describe new data as it pertains to the implications and options for patients as it pertains to their continued care

  • Apply updated guidelines for care for chronic liver and GI related diseases

  • Discuss future directions of therapeutics, diagnostics, and technology in the management of GI and liver diseases


Accreditation Statement

                                                    In support of improving patient care, this activity has been planned and implemented by Medical                                                        Education Resources (MER) and The Northern California Society for Clinical Gastroenterology. MER                                                is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the                                                      Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing                                                        Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation

Medical Education Resources designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


MOC Designation

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Disclosure of Relevant Financial Relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

This activity is supported by educational grants from AbbVie, Ferring Pharmaceuticals, Inc., Phathom Pharmaceuticals, Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A., Inc.



This activity is jointly provided by Medical Education Resources and the Northern California Society for Clinical Gastroenterology.

Screenshot 2023-03-30 105017.png

2023 NCSCG GI Symposium Faculty


Neena Abraham, MD
Mayo Clinic

Michaela Cerrato, PA-C
Stanford Digestive Health Center

Douglas Corley, MD
Kaiser Permanente San Francisco


Haddas Elisha, PA-C
Stanford Pelvic Health Center


Chris Hamerski, MD
Kaiser Permanente San Francisco


Edith Ho, MD
Stanford University

Edward Holt.png

William Holt, MD
California Pacific Medical Center


Priya Kathpalia, MD
University of California,
San Francisco


Abdul Kouanda, MD
University of California,
San Francisco


Uri Ladabaum, MD, MS
Stanford University


Marina Roytman, MD
University of California,
San Francisco – Fresno


Linda Nguyen, MD
Stanford University


Philip Schoenfeld, MD
John D. Dingell VA Medical Center/Evidence-Based GI: An ACG Publication


Neil Stollman, MD
East Bay Center for Digestive Health


Robert Wong, MD, MS
Stanford University
Palo Alto Veterans Affairs

bottom of page